| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Usana Health Sciences (NYSE:USNA) lowers FY2025 Adj EPS guidance from $2.35-$3.00 to $1.73 vs $1.70 analyst estimate. Narrows F...
Usana Health Sciences (NYSE:USNA) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of...
Editor’s Note: The future prices of benchmark tracking ETFs were updated in the story. U.S. stock futures rose on Friday aft...
US stock futures up, Apogee Enterprises, Levi Strauss, VolitionRX, USANA Health Sciences, Nurix Therapeutics report results.
Usana Health Sciences (NYSE:USNA) is looking for Q3 Adj EPS of $(0.15) vs $0.47 analyst estimate. sees sales of $214.000 millio...
Usana Health Sciences (NYSE:USNA) is looking for Q3 GAAP EPS of $(0.36) vs $0.44 analyst estimate..